Methylprednisolone Withdrawn Phase 2 Trials for Plasma Cell Myeloma Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01332617Phase II Study of Simvastatin for Relapsed/Refractory Myeloma